Showing results (1391-1400 of 1,400) with videos related to

Sort By:
Pageof 140
You have reached the last page of results.This site can display upto 1,400 results.
JCO Precision Oncology|August 7, 2026
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective StudyFrancesco Schettini, Alexandro Membrino, Giuseppe Di Grazia, et al.
JCO Precision Oncology|August 7, 2026
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel AssayHari Sankaran, Yuri Kotliarov, Yingdong Zhao, et al.
JCO Precision Oncology|August 4, 2026
Real-World Evidence for Oncology Patients With Rare NTRK Gene Fusions: Final Results From the German Multicenter Patient Cohort Study REALTRKKarin Potthoff, Sebastian Lange, Thomas Seufferlein, et al.
JCO Precision Oncology|August 21, 2026
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer TrialXiaolei Shi, Amol C Shetty, Jarey Wang, et al.
JCO Precision Oncology|August 26, 2026
Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor AzenosertibJinkil Jeong, Jianhui Ma, Mona Abed, et al.
JCO Precision Oncology|September 1, 2026
Establishing a Multicenter Personalized Medicine Program in Childhood, Adolescent, and Young Adult Cancer in Spain: The SEHOP-PENCIL ProjectAndrea Vilaplana, Asbleidy Carolina Torres, Adela Escudero López, et al.
JCO Precision Oncology|September 4, 2026
Clinical Relevance of Post-Treatment Circulating Tumor DNA Detection in Early Breast Cancer Using a Tissue-Free Epigenomic Assay: A 2-Year Landmark AnalysisThomas W P Friedl, Peter A Fasching, Andreas D Hartkopf, et al.
JCO Precision Oncology|September 4, 2026
Predicting Oral Cancer From Precursor Lesions: Assessing Current Methods and Future DirectionsMichael E Troka, James C Gates
JCO Precision Oncology|September 11, 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without AtezolizumabMarija Balic, Gong Tang, Priya Rastogi, et al.
JCO Precision Oncology|September 17, 2026
Clinicopathologic Features, Treatment Patterns, and Outcomes of Microsatellite Instability-High Gastric and Gastroesophageal Junction Adenocarcinoma: A Single-Institution Retrospective AnalysisDani Castillo, Pranati Shah, Natasha Setia, et al.
Pageof 140